CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-28 | Klein Dov Director | Sale | −5,000 | $2.45 | $12K | 651,015 |
| 2021-12-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,250 | $2.42 | $3K | 10,422,338 |
| 2021-11-16 | Klein Dov Director | Other acquisition | +230 | 656,015 | ||
| 2021-11-16 | Hoenlein Malcolm Director | Other acquisition | +230 | 435,636 | ||
| 2021-11-16 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Other acquisition | +4,619 | 10,421,088 | ||
| 2021-09-30 | Klein Dov Director | Other acquisition | +480 | 655,785 | ||
| 2021-09-30 | Hoenlein Malcolm Director | Other acquisition | +406 | 435,406 | ||
| 2021-09-30 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Other acquisition | +8,133 | 10,416,469 | ||
| 2021-09-21 | Hunter Robyn Chief Financial Officer | Sale | −28,292 | $3.13 | $89K | 163,877 |
| 2021-08-05 | Klein Dov Director | Other acquisition | +305 | 655,305 | ||
| 2021-06-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,297 | $2.31 | $3K | 10,408,336 |
| 2021-03-02 | Rowinsky Eric K Director | Sale | −10,000 | $4.45 | $45K | 720,000 |
| 2021-02-19 | Rowinsky Eric K Director | Sale | −8,000 | $4.31 | $34K | 730,000 |
| 2021-02-18 | Rowinsky Eric K Director | Sale | −6,000 | $4.20 | $25K | 738,000 |
| 2021-02-16 | Rowinsky Eric K Director | Sale | −2,000 | $3.86 | $8K | 744,000 |
| 2021-02-05 | Rowinsky Eric K Director | Sale | −4,000 | $3.80 | $15K | 746,000 |
| 2021-01-01 | WEISS MICHAEL S See Remarks | Grant or award | +1,030,339 | 11,232,150 | ||
| 2021-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 750,000 | ||
| 2021-01-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,030,339 | 10,407,039 | ||
| 2021-01-01 | Lorenz Kevin Director | Purchase | +50,000 | 214,582 |
Page 5 of 6 · 105 trades